Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FY9Y3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,747
Award facts
- Contract value 100% obligated
- $16,747.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,747.27 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office located in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, a $999,999,999.00 prime contract vehicle that extends through December 2026 and enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive federal contract portfolio demonstrates capability in delivering diverse pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This delivery order for Gemtesa, a urological medication, reflects the company's ongoing role in fulfilling specific pharmaceutical requirements within the broader defense healthcare ecosystem, where DLA Troop Support Medical is establishing generational prime vendor contracts to support distributed medical supply operations.
Quick answers
Who was awarded contract SPE2DR26FY9Y3?
SPE2DR26FY9Y3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FY9Y3 worth?
The government has obligated $16,747 on SPE2DR26FY9Y3.
Is contract SPE2DR26FY9Y3 an order under another contract?
Yes. SPE2DR26FY9Y3 is a delivery order under SPE2DR25D2018, an indefinite delivery contract.
Was contract SPE2DR26FY9Y3 competed?
The extent of competition for SPE2DR26FY9Y3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award